IN2014MU01185A - - Google Patents

Info

Publication number
IN2014MU01185A
IN2014MU01185A IN1185MU2014A IN2014MU01185A IN 2014MU01185 A IN2014MU01185 A IN 2014MU01185A IN 1185MU2014 A IN1185MU2014 A IN 1185MU2014A IN 2014MU01185 A IN2014MU01185 A IN 2014MU01185A
Authority
IN
India
Prior art keywords
cyclobenzaprine
salts
composition
release
mini
Prior art date
Application number
Other languages
English (en)
Inventor
Moinuddin Syed
Vishal Omprakash Daga
Rahul Sudhakar Dabre
Girish Kumar Jain
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1185MU2014 priority Critical patent/IN2014MU01185A/en
Priority to PCT/IB2015/051942 priority patent/WO2015150948A1/en
Publication of IN2014MU01185A publication Critical patent/IN2014MU01185A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1185MU2014 2014-03-29 2015-03-17 IN2014MU01185A (enrdf_load_html_response)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1185MU2014 IN2014MU01185A (enrdf_load_html_response) 2014-03-29 2015-03-17
PCT/IB2015/051942 WO2015150948A1 (en) 2014-03-29 2015-03-17 Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1185MU2014 IN2014MU01185A (enrdf_load_html_response) 2014-03-29 2015-03-17

Publications (1)

Publication Number Publication Date
IN2014MU01185A true IN2014MU01185A (enrdf_load_html_response) 2015-10-02

Family

ID=54395513

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1185MU2014 IN2014MU01185A (enrdf_load_html_response) 2014-03-29 2015-03-17

Country Status (1)

Country Link
IN (1) IN2014MU01185A (enrdf_load_html_response)

Similar Documents

Publication Publication Date Title
MX2021002321A (es) Nuevos metodos.
MX393855B (es) Terapia de combinación que comprende un inhibidor de raf y trametinib
MX2021000071A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
PH12017500746B1 (en) Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
MX2021004821A (es) Uso de antagonistas contra muerte programada 1 (pd-1) y ligando de muerte programada 1 (pd-l1) en combinacion con radioterapia.
MX382162B (es) Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer.
PH12016502352A1 (en) Pharmaceutical composition
PH12018500762A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
TW201613578A (en) Pharmaceutical combinations
MX381440B (es) Composicion farmaceutica para tratar colitis ulcerativa.
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
ZA201704327B (en) Methods and compositions for treating brain diseases
FI3445351T3 (fi) Asetyylileusiini tai sen farmaseuttisesti hyväksyttävä suola liikkuvuuden parantamiseen
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2019000849A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
IN2014MU01185A (enrdf_load_html_response)
IN2014MU01184A (enrdf_load_html_response)
MX2020005438A (es) Formas de dosificacion de sulfato de morfina disuasivas del abuso.
IN2014MU01187A (enrdf_load_html_response)
IN2014MU01186A (enrdf_load_html_response)
IN2013MU01155A (enrdf_load_html_response)
MX385725B (es) Composición farmacéutica que comprende sumatriptán para tratamiento de migraña.
IN2013MU01154A (enrdf_load_html_response)